References
1. Baddour Larry M., Bettmann Michael A., Bolger Ann F., et al.
Nonvalvular Cardiovascular Device–Related Infections.Circulation . 2003;108(16):2015-2031.
doi:10.1161/01.CIR.0000093201.57771.47
2. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of
pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.Clin Microbiol Rev . 2002;15(4):716-746.
doi:10.1128/cmr.15.4.716-746.2002
3. Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of Cardiac
Implantable Electronic Device Infections. JACC Clin
Electrophysiol . 2016;2(4):498-505. doi:10.1016/j.jacep.2016.01.019
4. Runyon EH. Conservation of the Specific Epithet fortuitum in the Name
of the Organism Known as Mycobacterium fortuitum da Costa Cruz: Request
for an Opinion. Int J Syst Bacteriol . 1972;22(1):50-51.
doi:10.1099/00207713-22-1-50
5. Phadke VK, Hirsh DS, Goswami ND. Patient Report and Review of Rapidly
Growing Mycobacterial Infection after Cardiac Device Implantation.Emerg Infect Dis . 2016;22(3):389-395. doi:10.3201/eid2203.150584
6. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An Official ATS/IDSA
Statement: Diagnosis, Treatment, and Prevention of Nontuberculous
Mycobacterial Diseases. Am J Respir Crit Care Med .
2007;175(4):367-416. doi:10.1164/rccm.200604-571ST
7. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart
Rhythm Association (EHRA) international consensus document on how to
prevent, diagnose, and treat cardiac implantable electronic device
infections—endorsed by the Heart Rhythm Society (HRS), the Asia
Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm
Society (LAHRS), International Society for Cardiovascular Infectious
Diseases (ISCVID) and the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) in collaboration with the European
Association for Cardio-Thoracic Surgery (EACTS). Eur J
Cardiothorac Surg . 2020;57(1):e1-e31. doi:10.1093/ejcts/ezz296
8. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac
implantable electronic device infection: a systematic review and
meta-analysis. EP Eur . 2015;17(5):767-777.
doi:10.1093/europace/euv053
9. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and
implantable cardioverter defibrillator infection: a population-based
study. Arch Intern Med . 2007;167(7):669-675.
doi:10.1001/archinte.167.7.669
10. Zhu J, Yang Q, Pan J, Shi H, Jin B, Chen Q. Cardiac
resynchronization therapy-defibrillator pocket infection caused by
Mycobacterium fortuitum: a case report and review of the literature.BMC Cardiovasc Disord . 2019;19. doi:10.1186/s12872-019-1028-0
11. Arnold CJ, Chu VH. Cardiovascular Implantable Electronic Device
Infections. Infect Dis Clin North Am . 2018;32(4):811-825.
doi:10.1016/j.idc.2018.06.004
12. Devana. Pacemaker site infection caused by Rapidly Growing
Nontuberculous Mycobacteria (RGM). Accessed February 6, 2020.
http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2018;volume=2;issue=1;spage=82;epage=84;aulast=Devana
13. Gill JS, Singh N, Khanna SP. Risk of cardiac pacemaker pocket
infection in a tertiary care hospital. Indian J Pathol Microbiol .
2017;60(2):185. doi:10.4103/IJPM.IJPM_190_16
14. De Groote MA, Huitt G. Infections Due to Rapidly Growing
Mycobacteria. Clin Infect Dis . 2006;42(12):1756-1763.
doi:10.1086/504381
15. Wallace RJ, Meier A, Brown BA, et al. Genetic basis for
clarithromycin resistance among isolates of Mycobacterium chelonae and
Mycobacterium abscessus. Antimicrob Agents Chemother .
1996;40(7):1676-1681. Accessed February 6, 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC163394/
16. Bharat V, Hittinahalli V, Mishra M, Pradhan S. Pacemaker pocket
infection due to environmental mycobacteria: Successful management of an
outbreak and steps for prevention in future. Indian Heart J .
2016;68(1):63-67. doi:10.1016/j.ihj.2015.06.023
Figures
Fig 1. Incision and drainage of the pocket infection